NCT01258998 2020-11-04Study of Akt Inhibitor MK2206 in Patients With Relapsed LymphomaNational Cancer Institute (NCI)Phase 2 Completed60 enrolled 8 charts
NCT01369849 2017-09-15Akt Inhibitor MK2206, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaNational Cancer Institute (NCI)Phase 1/2 Completed15 enrolled 13 charts
NCT01231919 2014-04-29MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or LeukemiaNational Cancer Institute (NCI)Phase 1 Completed45 enrolled